Cimed Is About to Open the Largest Pharmaceutical Factory in Latin America and, Besides Generating Many Jobs, the Company Plans to Expand Its Presence in the Domestic Market to 25%
The new Cimed Headquarters will elevate the company to the level of the largest pharmaceutical industry in Latin America, according to João Adibe Marques, the CEO of the company. According to the executive, a new pharmaceutical factory will be inaugurated in January next year, located in Pouso Alegre. The aim is to expand the domestic market share from 10% to 25%, in addition to generating up to 500 job openings. The group has also invested in space exploration in partnership with international institutions.
Read Other Related News
Largest Pharmaceutical Factory in Latin America Covers 770,000 m²
The new Cimed facility spans more than 770,000 m², which includes a pharmaceutical factory, printing park, and distribution center in São Sebastião da Bela Vista and Pouso Alegre, both in southern Minas.
-
Building a 95-square-meter house in 2026 can start at around R$ 185,000 at the reference base and exceed R$ 330,000 in high standard, but the final cost depends on the land, finishing, fees, and the region, with the South of the country being among the most expensive in Brazil.
-
A small church built in 7 weeks in 1961 stands surrounded by skyscrapers in Balneário Camboriú, the city with the most expensive square meter in Brazil, accommodating only 60 people and defying decades of verticalization and luxury on the coast of Santa Catarina.
-
Satellite images analyzed by Reuters reveal that China is building a vast network of over 80 launch platforms, bunkers, and communication centers in the Xinjiang desert near its nuclear silos, in an effort that analysts say aims to ensure the capability to retaliate in the event of an attack.
-
The Supreme Court approved Ferrogrão by nine votes to one, the railway that had been stalled for five years and is expected to provide a shorter route for soybeans from Mato Grosso to flow towards the north of the country.
According to company information, the projected revenue for this year is R$ 2.3 billion, which is 20% higher than in 2020. Products sold by the company represent 10% of all medications sold in the country.
In total, there are 450 million boxes sold per year, which come from the pharmaceutical factory. According to the Cimed executive, the new factory, which aims to be the largest in Latin America, only needs certification to be inaugurated and open job positions. The headquarters will allow the company to reach a capacity that is expected to account for almost 25% of everything sold in the country.
Cimed Promises to Generate Hundreds of Job Openings
Hiring for positions at the largest pharmaceutical factory in Latin America has already begun. According to Adibe, as the production lines receive certification, job openings will be created for professionals in the region.
The group expects to hire about 300 employees. In total, it should reach 500 job openings generated in the first year of operations, depending only on the certifications.
CLICK HERE TO VIEW THE COMPANY’S JOB LIST
Cimed Invests R$ 300 Million to Launch a Covid Virus Protein into Space
A rocket launched last week carried a Covid-19 virus protein into space through the Cimed X project. The investment in the project is approximately R$ 300 million. The international partnership for pharmaceutical research has the support of the U.S. space agency, NASA. According to the Cimed executive, the company is a sponsor of this project along with several agencies.
The initiative is pioneering among national companies in the sector. The rocket was launched with the goal of crystallizing the Covid-19 protein. The objective is to make discoveries outside of Earth’s orbit and conduct research that brings benefits to the global population.
Another focus of the space project is regenerative medicine. According to Adibe, this is a long-term project that needs to take between four to five years, and Cimed will use space specifically to speed up this process.

Be the first to react!